Table 2

Predictors of prescription of guideline-directed medical therapy compared with any of the other three treatment groups

Variable	Risk ratio	95% CI	P value
Age 65–79 (vs age ≥80) years	1.28	1.14 to 1.43	<0.001
Male	0.94	0.85 to 1.04	0.240
Hypertension	1.13	1.01 to 1.25	0.036
Diabetes	1.14	1.03 to 1.26	0.014
De novo heart failure (vs previous heart failure)	1.28	1.16 to 1.40	<0.001
Atrial fibrillation	1.01	0.89 to 1.13	0.911
Chronic kidney disease	0.86	0.77 to 0.96	0.004
Ischaemic CMP (vs non-ischaemic)	0.97	0.86 to 1.07	0.546
COPD	0.79	0.65 to 0.93	0.004
Discharge MRA	1.16	1.05 to 1.28	0.007
Discharge digoxin	0.97	0.86 to 1.09	0.634
Discharge loop diuretics	0.84	0.72 to 0.98	0.018

CMP, cardiomyopathy; COPD, chronic obstructive pulmonary disease; MRA, mineralocorticoid receptor antagonist.